CELIAC DISEASE ANTIBODY SELF-TEST - ANVISA Registration 81086830053
Access comprehensive regulatory information for CELIAC DISEASE ANTIBODY SELF-TEST in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81086830053 and manufactured by VEDALAB. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including BIOSYNEX SA, CHEMBIO DIAGNOSTICS BRAZIL LTDA., and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81086830053
25351652120202251
20037992000139
Company Information
Dates and Status
Jan 16, 2023
VIGENTE
09/18/2025 19:00:01
AUTOTESTE PARA ANTICORPO PARA DOENÇA CELÍACA
Biosynex Teste de Glúten
CHEMBIO DIAGNOSTICS BRAZIL LTDA.
80535240072
Dec 23, 2024
AUTOTESTE PARA ANTICORPO PARA DOENÇA CELÍACA
Gluten’ Alarm® Homeuse
VEDALAB
80464810865
Dec 04, 2023
AUTOTESTE PARA ANTICORPO PARA DOENÇA CELÍACA
BIOSYNEX Autoteste Glúten
BIOSYNEX SA
80686360311
Feb 25, 2021

